Roger Michael Gendreau's most recent trade in Dogwood Therapeutics Inc. was a trade of 12,075 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dogwood Therapeutics Inc. | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 12,075 | 12,075 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 88,085 | 88,085 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Roger Michael Gendreau | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 41,734 | 41,734 | - | - | Stock Option (right to buy) |